News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
4 Results
Section
Business (1)
Deals (1)
FDA (1)
News (3)
Policy (1)
Tag
Approvals (1)
FDA (1)
Mergers & acquisitions (1)
People (1)
Regulatory (1)
Date
2023 (1)
2021 (1)
2019 (1)
2017 (1)
4 Results for "custopharm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Leucadia Pharmaceuticals Launches Calcitonin Salmon Injection
Leucadia Pharmaceuticals, a U.S. leader in generic injectables and the commercial arm of Custopharm, Inc., today announced the launch of its latest FDA-approved generic, Calcitonin Salmon Injection, USP, Synthetic.
May 20, 2021
·
3 min read
Deals
Custopharm Acquires Two ANDA Pharmaceutical Products From Perrigo
January 4, 2017
·
2 min read
Business
Quantum-Si Announces the Appointment of Jeff Keyes as Chief Financial Officer
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jeff Keyes as its new Chief Financial Officer, effective May 15, 2023.
May 2, 2023
·
7 min read
FDA
Leucadia Pharmaceuticals Launches Sodium Tetradecyl Sulfate Injection
Eagerly Anticipated FDA-Approved Generic to SOTRADECOL® Provides Safe and Effective Solution for Patients, Bypasses Risks Presented by Lower-Quality Compounded Alternatives
December 11, 2019
·
3 min read
